The association between micronucleus, nucleoplasmic bridges, and nuclear buds frequency and the degree of uterine cervical lesions

References

• Aires, G.M.A., et al., 2011. Micronuclei as biomarkers for evaluating the risk of malignant transformation in the uterine cervix. Genetics and Molecular Research, 10 (3), 1558–1564.
   PubMed Web of Science ®Google Scholar
• Bennett, C., Kuhn, A.E., and Haverkos, H.W., 2010. Human papillomavirus and tar hypothesis for squamous cell cervical cancer. Journal of Biosciences, 35 (3), 331–337.
   PubMed Web of Science ®Google Scholar
• Bitgen, N., et al., 2016. Increased micronucleus, nucleoplasmic bridge, nuclear bud frequency and oxidative DNA damage associated with prolactin levels and pituitary adenoma diameters in patients with prolactinoma. Biotechnic & histochemistry, 91 (2), 128–136.
   PubMed Web of Science ®Google Scholar
• Bloching, M., et al., 2000. Exfoliative cytology of normal buccal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay. Oral oncology, 36, 550–555.
   PubMed Web of Science ®Google Scholar
• Boffetta, P., et al., 2007. Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. American Journal of Epidemiology, 165 (1), 36–43.
   PubMed Web of Science ®Google Scholar
• Bolognesi, C., et al., 2005. A molecular epidemiology case control study on pleural malignant mesothelioma. Cancer Epidemiology, Biomarkers & prevention, 14, 1741–1746.
   PubMed Web of Science ®Google Scholar
• Bolognesi, C., et al., 2015. Clinical application of micronucleus test in exfoliated buccal cells: a systematic review and metanalysis. Mutation research/reviews in mutation research, 766, 20–31.
   PubMed Web of Science ®Google Scholar
• Bonassi, S., et al., 2005. Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environmental and Molecular Mutagenesis, 45, 258–270.
   PubMed Web of Science ®Google Scholar
• Bonassi, S., et al., 2007. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis, 28, 625–631.
   PubMed Web of Science ®Google Scholar
• Bonassi, S., et al., 2008. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis, 29 (6), 1178–1183.
   PubMed Web of Science ®Google Scholar
• Bowman, K.J., et al., 2014. Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo. International Journal of Cancer, 134 (5), 1102–1111.
   PubMed Web of Science ®Google Scholar
• Bueno, C.T., et al., 2014. Association between cervical lesion grade and micronucleus frequency in the Papanicolaou. Genetics and Molecular Biology, 37 (3), 496–499.
   PubMed Web of Science ®Google Scholar
• Bulkmans, N.W., et al., 2007. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet, 370, 1764–1772.
   PubMed Web of Science ®Google Scholar
• Ceppi, M., et al., 2010. Human population studies with the exfoliated buccal micronucleus assay: statistical and epidemiological issues. Mutation research, 705 (1), 11–19.
   PubMed Web of Science ®Google Scholar
• Cortés-Gutiérrez, E.I., et al., 2012. Evaluation of DNA single and double strand breaks in women with cervical neoplasia based on alkaline and neutral comet assay techniques. Journal of Biomedicine and Biotechnology, 2012, 385245.
   PubMedGoogle Scholar
• Crasta, K., et al., 2012. DNA breaks and chromosome pulverization from errors in mitosis. Nature, 482 (7383), 53–58.
   PubMed Web of Science ®Google Scholar
• Donmez-Altuntas, H., et al., 2017. Increased chromosomal and oxidative DNA damage in patients with multinodular goiter and their association with cancer. International Journal of Endocrinology, 2017, 2907281.
   PubMed Web of Science ®Google Scholar
• Donmez-Altuntas, H., and Bitgen, N., 2012. Evaluation of the genotoxicity and cytotoxicity in the general population in Turkey by use of the cytokinesis-block micronucleus cytome assay. Mutation research, 748, 1–7.
   PubMed Web of Science ®Google Scholar
• El-Zein, R.A., et al., 2006. Cytokinesis blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer research, 66, 6449–6456.
   PubMed Web of Science ®Google Scholar
• El-Zein, R.A., et al., 2017. Identification of small and non-small cell lung cancer markers in peripheral blood using cytokinesis blocked micronucleus and spectral karyotyping assays. Cytogenetic and Genome Research, 152 (3), 122–131.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 1993. The cytokinesis-block micronucleus technichue: a detailed description of the method and its application to genotoxicity studies in human population. Mutation research, 285, 35–44.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 2002. Biomarkers of genetic damage for cancer epidemiology. Toxicology, 181, 411–416.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 2007. Cytokinesis-block micronucleus cytome assay. Nature protocols, 2, 1084–1104.
   PubMed Web of Science ®Google Scholar
• Fenech, M., et al., 2011. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis, 26 (1), 125–132.
   PubMed Web of Science ®Google Scholar
• Fenech, M., and Morley, A.A., 1985. Measurement of micronuclei in human lymphocytes. Mutation research, 147, 29–36.
   PubMed Web of Science ®Google Scholar
• Ferlay, J., et al., 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136, 5.
   Web of Science ®Google Scholar
• Gandhi, G., and Kaur, A., 2003. The micronucleus test in uterine epithelial cells of cervix cancer patients. Journal of Human Ecology, 14 (6), 445–449.
   Google Scholar
• Goodson, W.H. III, et al., 2015. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis, 36(Suppl. 1), S254–S296.
   PubMed Web of Science ®Google Scholar
• Haverkos, H.W., Haverkos, G.P., and O’Mara, M., 2017. Co-carcinogenesis: human papillomaviruses, coal tar derivatives, and squamous cell cervical cancer. Frontiers in microbiology, 8, 2253.
   PubMed Web of Science ®Google Scholar
• Ho, G.Y., et al., 1998. Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine, 338, 423–428.
   PubMed Web of Science ®Google Scholar
• Hoda, R.S., Loukeris, K., and Abdul-Karim, F.W., 2013. Gynecologic cytology on conventional and liquid-based preparations. A comprehensive review of similarities and differences. Diagnostic cytopathology, 41 (3), 257–278.
   PubMed Web of Science ®Google Scholar
• Holland, N., et al., 2008. The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps. Mutation research, 659, 93–108.
   PubMed Web of Science ®Google Scholar
• Iarmarcovai, G., et al., 2008. Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis. Mutation research, 659, 274–283.
   PubMed Web of Science ®Google Scholar
• Janssen, A., et al., 2011. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science, 333 (6051), 1895–1898.
   PubMed Web of Science ®Google Scholar
• Kahn, J.A., and Hillard, P.A., 2004. Human papilloma virus and cervical cytology in adolescents. Adolescent Medicine Clinics, 15 (2), 301–321.
   PubMedGoogle Scholar
• Keen-Kim, D., Nooraie, F., and Rao, P.N., 2008. Cytogenetic biomarkers for human cancer. Frontiers in Bioscience, 13, 5928–5949.
   PubMed Web of Science ®Google Scholar
• Loeb, L.A., Bielas, J.H., and Beckman, R.A., 2008. Cancers exhibit a mutator phenotype: clinical implications. Cancer Research, 68, 3551–3557.
   PubMed Web of Science ®Google Scholar
• Maher, V.M., et al., 1976. Frequency of ultraviolet light-induced mutations is higher in xerodermapigmentosum variant cells than in normal human cells. Nature, 261, 593–595.
   PubMed Web of Science ®Google Scholar
• Martins, R.A., et al., 2009. Biomonitoring of oral epithelial cells in petrol station attendants: comparison between buccal mucosa and lateral border of the tongue. Environment International, 35, 1062–1065.
   PubMed Web of Science ®Google Scholar
• McHugh, M.K., et al., 2013. Use of the cytokinesis-blocked micronucleus assay (CBMN) to detect gender differences and genetic instability in a lung cancer case-control study. Cancer Epidemiology, Biomarkers & prevention, 22 (1), 135–145.
   PubMed Web of Science ®Google Scholar
• Muñoz, N., et al., 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine, 348 (6), 518–527.
   PubMed Web of Science ®Google Scholar
• Murgia, E., et al., 2008. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case control study. Mutation Research, 639, 27–34.
   PubMed Web of Science ®Google Scholar
• Nanda, K., et al., 2000. Accuracy of the Papanicolaou test in screening for and follow up of cervical cytologic abnormalities: a systematic review. Annals of Internal Medicine, 132 (10), 810–819.
   PubMed Web of Science ®Google Scholar
• Nersesyan, A.K., 2007. Possible role of the micronucleus assay in diagnostics and secondary prevention of cervix cancer: a minireview. Cytology and genetics, 41 (5), 317–318.
   Web of Science ®Google Scholar
• Norppa, H., et al., 2006. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutation research, 600, 37–45.
   PubMed Web of Science ®Google Scholar
• Pampalona, J., et al., 2010. Telomere dysfunction and chromosome structure modulate the contribution of individual chromosomes in abnormal nuclear morphologies. Mutation research, 683 (1–2), 16–22.
   PubMed Web of Science ®Google Scholar
• Paterson, M.C., and Smith, P.J., 1979. Ataxia telangiectasia: an inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annual Review of Genetics, 13, 291–318.
   PubMed Web of Science ®Google Scholar
• Rajeswari, N., et al., 2000. Risk assessment in first degree female relatives of breast cancer patients using the alkaline Comet assay. Carcinogenesis, 21, 557–561.
   PubMed Web of Science ®Google Scholar
• Rossner, P., et al., 2005. Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environmental Health Perspectives, 113 (5), 517–520.
   PubMed Web of Science ®Google Scholar
• Rudolph, K.L., et al., 2001. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nature genetics, 28 (2), 155–159.
   PubMed Web of Science ®Google Scholar
• Sawaya, G.E., et al., 2005. Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health plan. Acta cytologica, 49, 391–397.
   PubMed Web of Science ®Google Scholar
• Solomon, E., Borrow, J., and Goddard, A.D., 1991. Chromosome aberrations and cancer. Science, 254, 1153–1160.
   PubMed Web of Science ®Google Scholar
• Souza, A.C., et al., 2016. Cytogenetic biomonitoring in buccal mucosa cells from women submitted to chemotherapy after mastectomy for breast cancer. Anticancer research, 36 (4), 1955–1958.
   PubMed Web of Science ®Google Scholar
• Shi, Y., et al., 2015. Association between micronucleus frequency and cervical intraepithelial neoplasia grade in Thinprep cytological test and its significance. International Journal of Clinical and Experimental Pathology, 8 (7), 8426–8843.
   PubMed Web of Science ®Google Scholar
• Stich, H.F., and Rosin, M.P., 1984. Micronuclei in exfoliated human cells as tool for studies in cancer risk and cancer intervention. Cancer letters, 22, 241–253.
   PubMed Web of Science ®Google Scholar
• Stratton, M.R., Campbell, P.J., and Futreal, P.A., 2009. The cancer genome. Nature, 458, 719–724.
   PubMed Web of Science ®Google Scholar
• Tolbert, P.E., Shy, C.M., and Allen, J.W., 1992. Micronuceli and other nuclear anomalies in buccal smears: methods development. Mutation research, 271, 69–77.
   PubMed Web of Science ®Google Scholar
• Thomas, P., et al., 2009. Buccal micronucleus cytome assay. Nature protocols, 4, 825–837.
   PubMed Web of Science ®Google Scholar
• Thomas, P., and Fenech, M., 2011. Cytokinesis-block micronucleus cytome assay in lymphocytes. Methods in Molecular Biology, 682, 217–234.
   PubMedGoogle Scholar
• Thompson, S.L., and Compton, D.A., 2008. Examining the link between chromosomal instability and aneuploidy in human cells. The Journal of Cell Biology, 180 (4), 665–672.
   PubMed Web of Science ®Google Scholar
• Valenciano, A., et al., 2013. Molecular biomarkers in the decision on treatment of cervical carcinoma patients. Clinical and Translational Oncology, 15 (8), 587–592.
   PubMed Web of Science ®Google Scholar
• Wei, L., et al., 2014. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. Carcinogenesis, 35 (10), 2373–2381.
   PubMed Web of Science ®Google Scholar
• Woodman, C.B., et al., 2001. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet, 357, 1831–1836.
   PubMed Web of Science ®Google Scholar
• Workowski, K.A., and Bolan, G.A., 2015. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and reports, 64 (RR-03), 1–137.
   PubMed Web of Science ®Google Scholar
• Zölzer, F., et al., 2017. Micronucleus frequency and content in healthy relatives of cancer patients. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 22 (7), 667–673.
   PubMed Web of Science ®Google Scholar
• zur Hausen, H., 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. Journal of the National Cancer Institute, 92, 690–698.
   PubMed Web of Science ®Google Scholar